| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 57 | 0.0x | 17.6x | Around median | |
Growth | 100 | — | 7.1% | Top tier | |
Quality | 60 | -40.6% | 4.5% | Around median | |
Safety | 91 | — | 2.6x | Top tier | |
Capital Return | 12 | — | 2.15% | Bottom tier | |
Momentum | 0 | -90.6% | 2.3% | Bottom tier | |
Sentiment | 2 | 1 | 3 | Bottom tier |
Enlivex Therapeutics Ltd. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Enlivex Therapeutics Ltd. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
Estimates — analyst targets and a simplified DCF, not investment advice.
AI analysis from the earnings call, financials and news
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
